D115 Unit 3 Videos: Bacterial Meningitis & Neurologic System Alterations

D115 Unit 3 Videos: Bacterial Meningitis & Neurologic System Alterations

Name

 Western Governors University

D115 Advanced Pathophysiology for the Advanced Practice Nurse

Prof. Name

Date

D115 Unit 3 Videos: Bacterial Meningitis & Neurologic System Alterations

Bacterial Meningitis

What is Bacterial Meningitis?

Bacterial meningitis refers to the inflammation of the meninges, specifically the pia mater and arachnoid mater, which are the delicate membranes enveloping the brain and spinal cord. This condition results from infections caused primarily by bacteria, but viruses, fungi, parasites, toxins, and even noninfectious triggers can also provoke meningitis. The inflammation can lead to severe neurological complications if untreated.

Which Pathogens Are Most Frequently Responsible?

The most common bacteria implicated in meningitis include Neisseria meningitidis (meningococcus), which remains a leading cause globally, and Streptococcus pneumoniae (pneumococcus), noted for its increasing resistance to antibiotics. The following table summarizes these key pathogens:

Pathogen	Notes
Neisseria meningitidis	Leading cause in various populations
Streptococcus pneumoniae	Frequently encountered; rising drug resistance

Who is at Increased Risk?

Certain groups have heightened vulnerability to bacterial meningitis. These include infants under one year old, adolescents, and adults over 40 years. Moreover, individuals residing in communal living environments such as college dormitories, military barracks, or certain regions like Sub-Saharan Africa face elevated risk due to outbreak potential.

What Factors Predispose Individuals to Meningitis?

Several conditions can increase susceptibility to bacterial meningitis. These include preexisting infections like otitis media (middle ear infection), sinusitis, and pneumonia. Additionally, states of immunosuppression, post-splenectomy status, and hematologic diseases such as sickle cell anemia particularly raise the risk of pneumococcal meningitis.

How is Bacterial Meningitis Transmitted?

Transmission occurs primarily through respiratory droplets or saliva, commonly spread via close contact behaviors like coughing, sneezing, kissing, or sharing utensils. Importantly, asymptomatic carriers can disseminate the infection unknowingly, facilitating community outbreaks.

What is the Pathophysiology of Bacterial Meningitis?

Bacteria typically gain entry through the respiratory tract or bloodstream and may also enter following neurosurgical procedures. Upon crossing the blood-brain barrier, these pathogens multiply in the cerebrospinal fluid (CSF) and secrete toxins that increase blood vessel permeability. This process induces cerebral edema and disrupts CSF flow, elevating intracranial pressure. Without intervention, this can lead to brainstem herniation and death.

What Clinical Manifestations Are Observed?

The clinical features of bacterial meningitis can be categorized as follows:

Symptom Category	Symptoms
Systemic Signs	Fever, chills, tachycardia
Meningeal Signs	Severe headache, photophobia, neck stiffness, positive Kernig and Brudzinski signs
Neurologic Signs	Altered consciousness, seizures, hemiparesis, confusion, projectile vomiting, papilledema, petechial rash, bulging fontanels (infants), and opisthotonic posturing (children)

How is Bacterial Meningitis Diagnosed?

Diagnosis is confirmed through lumbar puncture, which reveals elevated white blood cells in the CSF. Blood cultures are also essential for identifying the specific causative bacteria, guiding targeted therapy.

What are the Treatment Protocols?

Immediate initiation of empiric intravenous antibiotics is critical, later tailored according to culture sensitivity results. In cases caused by pneumococcus, adjunctive dexamethasone therapy is recommended to reduce inflammatory damage. Supportive care remains fundamental in managing complications.

What Complications Can Arise?

Complications from bacterial meningitis can be severe, including septic shock, disseminated intravascular coagulation (DIC), purpura fulminans, and multi-organ failure, necessitating prompt and aggressive treatment.

How Can Bacterial Meningitis be Prevented?

Vaccination plays a pivotal role in prevention. Immunizations targeting Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type B have significantly reduced incidence rates.

---

Guillain-Barré Syndrome (GBS)

What is Guillain-Barré Syndrome?

GBS is an acute autoimmune disorder affecting the peripheral nervous system, characterized by demyelination and progressive, symmetrical muscle weakness starting in the lower limbs and ascending upwards.

What Triggers GBS?

GBS often develops following infections or immune activations. Common antecedents include infections with Campylobacter jejuni, cytomegalovirus (CMV), Epstein-Barr virus (EBV), influenza virus, Mycoplasma pneumoniae, and Zika virus. Occasionally, surgical procedures or vaccinations may trigger the syndrome.

What Underlies the Pathophysiology of GBS?

Molecular mimicry prompts the immune system to produce antibodies that mistakenly attack peripheral nerve myelin or axons. Complement system activation further impairs nerve conduction, culminating in the neurological deficits observed.

What Are the Subtypes of Guillain-Barré Syndrome?

Subtype	Description
Acute inflammatory demyelinating polyneuropathy (AIDP)	The most prevalent variant, involving demyelination of peripheral nerves
Acute motor axonal neuropathy (AMAN)	Primarily affects motor nerves
Acute motor-sensory axonal neuropathy (AMSAN)	Affects both motor and sensory nerves
Miller Fisher syndrome	Rare form marked by ataxia, ophthalmoplegia, and absence of reflexes

What Symptoms Are Characteristic?

GBS presents with ascending flaccid paralysis, sensory disturbances such as paresthesia, muscle weakness, and absent reflexes. Autonomic dysfunction is common, and respiratory muscle paralysis can develop within two weeks, necessitating urgent medical attention.

How is GBS Diagnosed?

Diagnosis is based on the clinical picture of progressive weakness in at least two limbs, areflexia, and rapid symptom progression within four weeks.

What Treatment Options Exist?

Therapies include intravenous immunoglobulin (IVIG) and plasmapheresis, which modulate the immune response. Early and intensive rehabilitation is critical for functional recovery.

What is the Prognosis?

Recovery varies, typically ranging from weeks to months, with some patients requiring up to two years. Approximately 30% of individuals may have residual muscle weakness after recovery.

---

Multiple Sclerosis (MS)

What is Multiple Sclerosis?

MS is a chronic autoimmune disorder of the central nervous system (CNS), characterized by inflammatory demyelination of nerve fibers and subsequent neurological disability.

What is the Pathophysiology?

Activated T-cells breach the blood-brain barrier and release inflammatory cytokines that damage oligodendrocytes, the myelin-producing cells in the CNS. This damage forms demyelinated plaques, visible on MRI scans. Although initial remyelination attempts occur, this process diminishes with disease progression.

Who is Most at Risk?

Risk factors include female sex, presence of the HLA-DR2 gene, vitamin D deficiency, and residing in higher latitudes (further from the equator).

What Types of MS Are Recognized?

Type	Description
Relapsing-remitting	Characterized by episodes of neurological symptoms followed by recovery; most common
Secondary progressive	Begins as relapsing-remitting but transitions to steady progression
Primary progressive	Continuous worsening of symptoms from disease onset
Progressive-relapsing	Progressive decline with occasional acute relapses

What Are the Typical Symptoms?

MS usually manifests between 20 and 40 years of age. Patients commonly experience motor deficits such as weakness, tremor, spasticity, and ataxia. Sensory symptoms include numbness and paresthesia. Visual problems like optic neuritis and diplopia, speech difficulties (dysarthria), autonomic dysfunction, cognitive impairment, and mood disorders such as depression are frequent. Charcot’s triad—dysarthria, nystagmus, and intention tremor—is characteristic.

How is MS Diagnosed?

Diagnosis involves MRI to detect demyelinating plaques, CSF analysis for oligoclonal bands, visual evoked potentials, and clinical assessment demonstrating symptom dissemination in time and space.

What Treatments Are Available?

Acute MS exacerbations are treated with corticosteroids, IVIG, or plasmapheresis. Disease-modifying therapies, including interferon-beta and immunosuppressants, aim to reduce relapse frequency. Rehabilitation targets symptom management and functional improvement.

---

Myasthenia Gravis

What is Myasthenia Gravis?

Myasthenia Gravis is a chronic autoimmune disorder characterized by fluctuating skeletal muscle weakness resulting from impaired neuromuscular transmission.

What Causes Myasthenia Gravis?

The disease results from autoantibodies targeting acetylcholine receptors at the neuromuscular junction, disrupting signal transmission from nerve to muscle.

What Are the Typical Symptoms?

Patients often exhibit ptosis (drooping eyelids), diplopia (double vision), facial muscle weakness, and difficulties with chewing, swallowing, and speaking. Weakness commonly affects the limbs and neck, and symptoms typically improve after periods of rest.

How is the Diagnosis Established?

Diagnostic Tool	Purpose
Acetylcholine receptor antibodies	Detects pathogenic autoantibodies
Anti-MuSK antibodies	Alternative antibody testing
Electromyography (EMG)	Evaluates neuromuscular transmission
Edrophonium test	Assesses transient symptom improvement
CT/MRI	Identifies thymoma presence

What Are the Treatment Strategies?

Treatment includes anticholinesterase medications, immunosuppressants, and thymectomy if a thymoma is present. During exacerbations, IVIG or plasmapheresis is utilized.

---

Diabetes Mellitus

Overview

Diabetes Mellitus is a metabolic disorder characterized by chronic hyperglycemia resulting from inadequate insulin production or insulin resistance.

How is Blood Glucose Regulated?

Insulin, produced by pancreatic β-cells, lowers blood glucose levels, while glucagon raises them. Both hormones are secreted by the pancreatic islets to maintain glucose homeostasis.

Type 1 Diabetes Mellitus

Type 1 diabetes arises from autoimmune destruction of pancreatic β-cells, leading to absolute insulin deficiency. It is associated with HLA-DR3 and DR4 genotypes and presents with classic symptoms such as polyphagia, polyuria, polydipsia, and glycosuria. Diabetic ketoacidosis (DKA) is a significant complication, and lifelong insulin therapy is essential.

Type 2 Diabetes Mellitus

Characterized by insulin resistance coupled with relative insulin deficiency, type 2 diabetes strongly correlates with obesity and genetic factors. Complications include hyperosmolar hyperglycemic state (HHS). Management emphasizes lifestyle modifications, oral hypoglycemic agents (e.g., metformin), and insulin when required.

How is Diabetes Diagnosed? (WHO Criteria)

Test	Diagnostic Threshold
Fasting glucose	≥126 mg/dL
Random glucose	≥200 mg/dL
Oral glucose tolerance test (OGTT)	≥200 mg/dL at 2 hours
HbA1c	≥6.5%

---

Hyperparathyroidism

What is Hyperparathyroidism?

This disorder involves excessive secretion of parathyroid hormone (PTH), resulting in elevated serum calcium levels.

Types of Hyperparathyroidism

Type	Cause
Primary	Parathyroid adenoma or hyperplasia
Secondary	Chronic hypocalcemia due to chronic kidney disease or vitamin D deficiency
Tertiary	Autonomous PTH secretion following prolonged secondary hyperparathyroidism

What Symptoms are Common?

Clinical manifestations include kidney stones, bone pain, fractures, osteoporosis, gastrointestinal symptoms (constipation, nausea), neuropsychiatric disturbances, polyuria, and polydipsia.

How is it Managed?

Surgical removal is the mainstay for primary hyperparathyroidism. Secondary cases focus on correcting vitamin D and phosphate imbalances, often using calcimimetics like cinacalcet.

---

Thyroid Disorders

Hyperthyroidism (Graves’ Disease)

This autoimmune disorder results from antibodies stimulating the thyroid-stimulating hormone (TSH) receptor. Symptoms include weight loss, tremors, anxiety, and heat intolerance. Laboratory tests reveal low TSH and elevated T3 and T4. Treatment includes antithyroid medications, beta-blockers, and sometimes surgery. Thyroid storm is a critical emergency requiring intensive care.

Hypothyroidism (Hashimoto’s Thyroiditis)

Hashimoto’s thyroiditis involves autoimmune destruction of the thyroid gland, leading to symptoms like fatigue, weight gain, and cold intolerance. Levothyroxine replacement therapy is the standard treatment.

---

Otitis Media

What is Otitis Media?

Otitis media is an inflammation of the middle ear, predominantly affecting pediatric populations.

How is Otitis Media Diagnosed?

Diagnosis is made by identifying decreased tympanic membrane mobility, confirmed through tympanometry or pneumatic otoscopy.

What is the Recommended Treatment?

High-dose amoxicillin is the first-line therapy, while watchful waiting is advised in mild or non-severe cases.

---

Mental Health Disorders

Disorder	Definition	Treatment
Depression	Persistent depressed mood ≥2 weeks	SSRIs, psychotherapy, or combination therapy
Generalized Anxiety Disorder (GAD)	Excessive worry lasting ≥6 months	Cognitive Behavioral Therapy (CBT), SSRIs/SNRIs
Schizophrenia	Psychotic disorder with positive, negative, and cognitive symptoms	Antipsychotics and psychosocial therapy

---

References

American Diabetes Association. (2023). Classification and diagnosis of diabetes. Diabetes Care, 46(Supplement_1), S19–S33. https://doi.org/10.2337/dc23-S002

Harrison, T. R. (2018). Harrison’s Principles of Internal Medicine (20th ed.). McGraw-Hill Education.

Jameson, J. L., Fauci, A. S., Kasper, D. L., Hauser, S. L., Longo, D. L., & Loscalzo, J. (2018). Harrison’s Manual of Medicine (19th ed.). McGraw-Hill Education.

Kumar, V., Abbas, A. K., & Aster, J. C. (2020). Robbins Basic Pathology (10th ed.). Elsevier.

The post D115 Unit 3 Videos: Bacterial Meningitis & Neurologic System Alterations appeared first on NURSFPX.com.